Tumor response (immune related - irRC)

ResponseAll patients
n = 30
No. of pts. (%)
irBOR
 irCR1 (3)
 irPR7 (23)
 irSD9 (30)
 irPD13 (43)
 irDCR17 (57)
 irCBR13 (43)
 irBORR8 (27)

ir immune related, BOR best overall response, CR complete response, PR partial response, SD stable disease, PD progressive disease, BORR best overall response rate, DCR disease control rate (CR + PR + SD), CBR clinical benefit rate (CR + PR + SD ≥ 24 weeks)